These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 26503145)

  • 21. Nanotechnology-based intelligent drug design for cancer metastasis treatment.
    Gao Y; Xie J; Chen H; Gu S; Zhao R; Shao J; Jia L
    Biotechnol Adv; 2014; 32(4):761-77. PubMed ID: 24211475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.
    Fernandez-Fernandez A; Manchanda R; McGoron AJ
    Appl Biochem Biotechnol; 2011 Dec; 165(7-8):1628-51. PubMed ID: 21947761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward the next-generation nanomedicines: design of multifunctional multiblock polyurethanes for effective cancer treatment.
    Ding M; Song N; He X; Li J; Zhou L; Tan H; Fu Q; Gu Q
    ACS Nano; 2013 Mar; 7(3):1918-28. PubMed ID: 23411462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature.
    Karabasz A; Bzowska M; Szczepanowicz K
    Int J Nanomedicine; 2020; 15():8673-8696. PubMed ID: 33192061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aptamer-guided nanomedicines for anticancer drug delivery.
    Alshaer W; Hillaireau H; Fattal E
    Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
    Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK
    Curr Med Chem; 2024; 31(28):4479-4494. PubMed ID: 37828674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy.
    Duangrat R; Udomprasert A; Kangsamaksin T
    Cancer Sci; 2020 Sep; 111(9):3164-3173. PubMed ID: 32589345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
    Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
    Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand decorated biodegradable nanomedicine in the treatment of cancer.
    Ahmad E; Ali A; Fatima MT; Nimisha ; Apurva ; Kumar A; Sumi MP; Sattar RSA; Mahajan B; Saluja SS
    Pharmacol Res; 2021 May; 167():105544. PubMed ID: 33722711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of chitosan-based nanocarriers in tumor-targeted drug delivery.
    Ghaz-Jahanian MA; Abbaspour-Aghdam F; Anarjan N; Berenjian A; Jafarizadeh-Malmiri H
    Mol Biotechnol; 2015 Mar; 57(3):201-18. PubMed ID: 25385004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition.
    He Q; Shi J
    Adv Mater; 2014 Jan; 26(3):391-411. PubMed ID: 24142549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
    Saravanakumar K; Hu X; Ali DM; Wang MH
    Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Advances in Targeted Tumor Chemotherapy Based on Smart Nanomedicines.
    Qin SY; Zhang AQ; Zhang XZ
    Small; 2018 Nov; 14(45):e1802417. PubMed ID: 30247806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug and gene co-delivery systems for cancer treatment.
    Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
    Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
    Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
    Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actively targeted nanocarriers for drug delivery to cancer cells.
    Biffi S; Voltan R; Bortot B; Zauli G; Secchiero P
    Expert Opin Drug Deliv; 2019 May; 16(5):481-496. PubMed ID: 30955393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
    Raza F; Zafar H; You X; Khan A; Wu J; Ge L
    J Mater Chem B; 2019 Dec; 7(48):7639-7655. PubMed ID: 31746934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smart Drug-Delivery Systems for Cancer Nanotherapy.
    Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
    Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.